← Back to Search

Meditation for Improved Brain Blood Flow During Sleep

N/A
Recruiting
Led By Daniel Claassen, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 14-45
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 24 hours
Awards & highlights

Study Summary

This trial uses MRI to study how meditation affects the brain's blood flow and metabolism.

Who is the study for?
This trial is for people aged 14-45 who are skilled in meditation. They must be able to undergo MRI scans, meaning no metal implants or issues with confined spaces. Participants should not have recent infections, tattoos, wounds, or consume stimulants/alcohol before the visit. Those with major neurological/psychological conditions or on certain medications like opioids and MAO inhibitors cannot join.Check my eligibility
What is being tested?
The study is testing how different states like sleep and meditation affect brain functioning related to fluid movement and metabolism in healthy volunteers using advanced MRI techniques.See study design
What are the potential side effects?
Since this trial involves MRI scanning and meditation without any drugs or invasive procedures, there are minimal side effects expected beyond the discomfort of lying still for long periods during imaging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 14 and 45 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CSF flow change
Secondary outcome measures
EEG changes

Trial Design

1Treatment groups
Experimental Treatment
Group I: Adept MeditatorsExperimental Treatment1 Intervention
Subjects will undergo scanning during awake, sleep deprived, and meditative states of consciousness.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Meditation
2021
Completed Phase 3
~2740

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
856 Previous Clinical Trials
672,152 Total Patients Enrolled
Daniel Claassen, MDPrincipal InvestigatorVanderbilt University Medical Center
2 Previous Clinical Trials
107 Total Patients Enrolled

Media Library

Meditation Clinical Trial Eligibility Overview. Trial Name: NCT04506892 — N/A
Sleep Clinical Trial 2023: Meditation Highlights & Side Effects. Trial Name: NCT04506892 — N/A
Meditation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04506892 — N/A
Sleep Research Study Groups: Adept Meditators

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the participant eligibility for this clinical trial restricted to persons 75 years and younger?

"This clinical trial calls for participants to be in the 18-45 age range. Patients below 18 years of age have 58 trials available, and individuals over 65 can look into 574 different studies."

Answered by AI

How many individuals are currently involved in this clinical research?

"Affirmative. Details posted on clinicaltrials.gov demonstrate that this research endeavor, which was initially uploaded to the website on February 1st 2021, is currently in search of participants. 40 patients must be sourced from a single medical center for participation in the trial."

Answered by AI

Are researchers currently looking to add participants for this experiment?

"Evidence hosted on clinicaltrials.gov confirms that this medical trial remains open to recruitment, with the initial posting occurring on February 1st 2021 and updates having been made as recently as April 14th 2022."

Answered by AI

To what extent is eligibility for this trial restricted?

"This study is inviting 40 individuals suffering from parkinson's and aged between 14-45 to participate. Special consideration will be given to those with "Adept meditator status"."

Answered by AI

Who else is applying?

What state do they live in?
Florida
Tennessee
How old are they?
18 - 65
What site did they apply to?
Vanderbilt University Medical Center
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
Quantitation of Glymphatic Functioning in Sleep and Meditative States
Daniel Claassen 2021. "Quantitation of Glymphatic Functioning in Sleep and Meditative States". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04506892.
All > Parkinsons Disease > Parkinson Disease
~16 spots leftby Jul 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top